Neuland Laboratories Limited (BOM: 524558)

Neuland Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	178,348	80,588	23,087	13,171	26,788	3,637
Market Cap Growth	235.77%	249.07%	75.28%	-50.83%	636.62%	-57.97%
Enterprise Value	177,540	80,232	24,941	15,076	28,580	5,175
Last Close Price	13901.00	6270.44	1790.15	1017.00	2065.30	279.90
PE Ratio	63.77	26.86	14.12	20.64	33.22	22.43
Forward PE	53.30	25.58	20.20	15.19	28.71	7.25
PS Ratio	11.67	5.17	1.94	1.38	2.86	0.48
PB Ratio	12.78	6.28	2.32	1.57	3.41	0.51
P/TBV Ratio	14.27	8.05	3.24	2.36	5.32	0.85
P/FCF Ratio	431.38	68.58	13.49	-	31.90	42.56
P/OCF Ratio	64.71	30.86	9.73	21.81	14.15	6.34
PEG Ratio	0.59	0.59	0.59	0.59	0.59	0.59
EV/Sales Ratio	11.62	5.15	2.09	1.58	3.05	0.68
EV/EBITDA Ratio	42.97	17.49	8.93	10.74	19.72	5.06
EV/EBIT Ratio	50.69	19.89	10.82	15.69	26.07	7.03
EV/FCF Ratio	429.42	68.28	14.58	-	34.04	60.57
Debt / Equity Ratio	0.08	0.07	0.13	0.29	0.23	0.37
Debt / EBITDA Ratio	0.26	0.21	0.46	1.67	1.23	2.54
Debt / FCF Ratio	2.65	0.81	0.75	-	2.17	30.87
Asset Turnover	0.85	0.91	0.80	0.70	0.73	0.65
Inventory Turnover	2.14	2.33	2.25	2.16	2.37	2.32
Quick Ratio	1.20	1.10	0.95	0.69	0.63	0.61
Current Ratio	2.34	2.15	1.73	1.60	1.49	1.44
Return on Equity (ROE)	22.13%	26.36%	17.83%	7.85%	10.78%	2.30%
Return on Assets (ROA)	12.13%	14.78%	9.73%	4.43%	5.36%	3.90%
Return on Capital (ROIC)	15.99%	20.16%	13.08%	5.86%	7.06%	4.83%
Earnings Yield	1.57%	3.72%	7.08%	4.85%	3.01%	4.46%
FCF Yield	0.23%	1.46%	7.41%	-2.83%	3.13%	2.35%
Dividend Yield	0.10%	0.22%	0.56%	0.49%	0.24%	0.71%
Payout Ratio	6.42%	4.28%	3.92%	6.03%	3.18%	30.53%
Buyback Yield / Dilution	-0.01%	-	-	-	-	-1.93%
Total Shareholder Return	0.10%	0.22%	0.56%	0.49%	0.24%	-1.22%

Source: S&P Capital IQ. Standard template. Financial Sources.